GPX4 and non-small cell lung carcinoma: In summary, this study provides evidence that SL–GAC can enhance the radiosensitivity of NSCLC cells by inducing ferroptosis, and the Nrf2/SLC7A11/GPX4 pathway has important regulation roles, indicating its potential as a radiotherapy sensitizer for NSCLC.